SCHEMBL4432379

SCHEMBL4432379

CSc1nc(-c2cccc(N)c2)c2c(N)c(C(N)=O)ccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LHCGR P22888 6/20 0.43
TSHR P16473 1/20 0.42
PARP1 P09874 1/20 0.40
PLK4 O00444 1/20 0.40
MAP4K4 O95819 1/20 0.40
EGFR P00533 1/20 0.40
ROS1 P08922 1/20 0.40
PIM1 P11309 1/20 0.40
AXL P30530 1/20 0.40
FLT3 P36888 1/20 0.40
FRK P42685 1/20 0.40
MAP4K2 Q12851 1/20 0.40
NTRK3 Q16288 1/20 0.40
MINK1 Q8N4C8 1/20 0.40
AURKB Q96GD4 1/20 0.40
HIPK2 Q9H2X6 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
STK17A Q9UEE5 1/20 0.40
ALK Q9UM73 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423221 0.91 LHCGR (0.41) LHCGRTSHRBRAFPDE4APDE4B
SCHEMBL4423903 0.90 LHCGR (0.54) LHCGRTSHRPARP1EGFRFLT3
SCHEMBL4422167 0.87 LHCGR (0.55) LHCGRTSHRBRAFPDE4APDE4B
SCHEMBL4418728 0.87 LHCGR (0.57) LHCGRTSHRPARP1BRAFPDE4A
SCHEMBL4421572 0.85 SMN1; SMN2 (0.50) LHCGRTSHRKDM4ESMN1; SMN2CSNK1D
SCHEMBL4422529 0.82 JAK3 (0.42) LHCGRTSHRMAP4K4BRAFKMT2A
SCHEMBL4425074 0.81 LHCGR (0.45) LHCGRTSHRMAP4K4BRAFKMT2A
SCHEMBL4422170 0.80 LHCGR (0.42) LHCGRTSHRPARP1PLK4MAP4K4
SCHEMBL4423898 0.78 LHCGR (0.55) LHCGRTSHRBRAFPDE4APDE4B
SCHEMBL4430421 0.78 LHCGR (0.66) LHCGRTSHREGFRFLT3MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618963-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2009-11-17 US disclosed
US-20070197527-A1 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-08-23 US disclosed
US-7229990-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-06-12 US disclosed
US-20030225113-A1 Bicyclic heteroaromatic compounds MERCK SHARP & DOHME B.V. (NL) 2003-12-04 US disclosed
EP-1322651-A1 BICYCLIC HETEROAROMATIC COMPOUNDS Akzo Nobel N.V. (NL) 2003-07-02 EP disclosed
WO-2002024703-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AKZO NOBEL N.V. (NL) 2002-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225113-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 13/4885TSHR 1000/4885PARP1 2182/4885
US-20070197527-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 10/4885TSHR 517/4885PARP1 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.